FdaApplication
ANDA 217114
Identifiers
- fda_app_no: ANDA217114
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2023-08-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MARAVIROC | MARAVIROC | 300MG | TABLET;ORAL |
| MARAVIROC | MARAVIROC | 150MG | TABLET;ORAL |
2 products